John L. Higgins

2011

In 2011, John L. Higgins earned a total compensation of $1.6M as President and Chief Executive Officer at Ligand Pharmaceuticals, a 36% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$317,888
Option Awards$738,128
Salary$423,850
Stock Awards$150,750
Other$2,540
Total$1,633,156

Higgins received $738.1K in option awards, accounting for 45% of the total pay in 2011.

Higgins also received $317.9K in non-equity incentive plan, $423.9K in salary, $150.8K in stock awards and $2.5K in other compensation.

Rankings

In 2011, John L. Higgins' compensation ranked 3,938th out of 10,747 executives tracked by ExecPay. In other words, Higgins earned more than 63.4% of executives.

ClassificationRankingPercentile
All
3,938
out of 10,747
63rd
Division
Manufacturing
1,385
out of 3,960
65th
Major group
Chemicals And Allied Products
280
out of 1,038
73rd
Industry group
Drugs
160
out of 786
80th
Industry
Pharmaceutical Preparations
130
out of 571
77th
Source: SEC filing on April 21, 2014.

Higgins' colleagues

We found three more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2011.

2011

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2011

John Sharp

Ligand Pharmaceuticals

Chief Financial Officer

2011

Charles Berkman

Ligand Pharmaceuticals

General Counsel

News

You may also like